Establishment of a novel minigenome system for the identification of drugs targeting Nipah virus replication

References

1. Gazal S, Sharma N, Gazal S, Tikoo M, Shikha D et al. Nipah and hendra viruses: deadly zoonotic paramyxoviruses with the potential to cause the next pandemic. Pathogens 2022; 11:1419 [View Article] [PubMed]
   [Google Scholar]
2. Skowron K, Bauza-Kaszewska J, Grudlewska-Buda K, Wiktorczyk-Kapischke N, Zacharski M et al. Nipah virus-another threat from the world of zoonotic viruses. Front Microbiol 2021; 12:811157 [View Article] [PubMed]
   [Google Scholar]
3. Hannemann H. Viral replicons as valuable tools for drug discovery. Drug Discov Today 2020; 25:1026–1033 [View Article] [PubMed]
   [Google Scholar]
4. Nelson EV, Pacheco JR, Hume AJ, Cressey TN, Deflubé LR et al. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening. Antiviral Res 2017; 146:21–27 [View Article] [PubMed]
   [Google Scholar]
5. Freiberg A, Dolores LK, Enterlein S, Flick R. Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA. Virology 2008; 370:33–44 [View Article] [PubMed]
   [Google Scholar]
6. Liu S, Chou CK, Wu WW, Luan B, Wang TT. Stable cell clones harboring self-replicating SARS-CoV-2 RNAs for drug screen. J Virol 2022; 96:e0221621 [View Article] [PubMed]
   [Google Scholar]
7. Saito K, Shimasaki K, Fukasawa M, Suzuki R, Okemoto-Nakamura Y et al. Establishment of vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon. Virus Res 2022; 322:198935 [View Article] [PubMed]
   [Google Scholar]
8. Li J-Q, Deng C-L, Gu D, Li X, Shi L et al. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus. Antiviral Res 2018; 150:148–154 [View Article] [PubMed]
   [Google Scholar]
9. Kato F, Nio Y, Yagasaki K, Suzuki R, Hijikata M et al. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase. Antiviral Res 2019; 172:104643 [View Article] [PubMed]
   [Google Scholar]
10. Tao W, Gan T, Guo M, Xu Y, Zhong J. Novel stable ebola virus minigenome replicon reveals remarkable stability of the viral genome. J Virol 2017; 91:22 [View Article] [PubMed]
    [Google Scholar]
11. Halpin K, Bankamp B, Harcourt BH, Bellini WJ, Rota PA. Nipah virus conforms to the rule of six in a minigenome replication assay. J Gen Virol 2004; 85:701–707 [View Article] [PubMed]
    [Google Scholar]
12. Kim JH, Lee S-R, Li L-H, Park H-J, Park J-H et al. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 2011; 6:e18556 [View Article] [PubMed]
    [Google Scholar]
13. Sweeney NP, Vink CA. The impact of lentiviral vector genome size and producer cell genomic to gag-pol mRNA ratios on packaging efficiency and titre. Mol Ther Methods Clin Dev 2021; 21:574–584 [View Article] [PubMed]
    [Google Scholar]
14. Sun Y, Liu G, Huang Y, Lu X. Applications of piggyBac transposons for genome manipulation in stem cells. Stem Cells Int 2021; 2021:3829286 [View Article] [PubMed]
    [Google Scholar]
15. Dawes BE, Kalveram B, Ikegami T, Juelich T, Smith JK et al. Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci Rep 2018; 8:7604 [View Article] [PubMed]
    [Google Scholar]
16. Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P et al. GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses. Sci Rep 2017; 7:43395 [View Article] [PubMed]
    [Google Scholar]
17. Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol 2001; 49:810–813 [View Article] [PubMed]
    [Google Scholar]
18. Lo MK, Feldmann F, Gary JM, Jordan R, Bannister R et al. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Sci Transl Med 2019; 11:494 [View Article] [PubMed]
    [Google Scholar]
19. Iampietro M, Aurine N, Dhondt KP, Dumont C, Pelissier R et al. Control of nipah virus infection in mice by the host adaptors Mitochondrial Antiviral Signaling Protein (MAVS) and Myeloid Differentiation Primary Response 88 (MyD88). J Infect Dis 2020; 221:S401–S406 [View Article] [PubMed]
    [Google Scholar]
20. Dhondt KP, Mathieu C, Chalons M, Reynaud JM, Vallve A et al. Type I interferon signaling protects mice from lethal henipavirus infection. J Infect Dis 2013; 207:142–151 [View Article] [PubMed]
    [Google Scholar]
21. Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler CF. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J Virol 2009; 83:7828–7841 [View Article] [PubMed]
    [Google Scholar]